Blackstone Group »

Cytokinetics shares owned by Blackstone Group

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Blackstone Group from 13F filings

Historical chart of Blackstone Group investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Blackstone Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Blackstone Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $222k 3.4k 65.91

More positions owned by Blackstone Group

Cheniere Energy Partners Com Unit (CQP)
Corebridge Finl (CRBG)
FirstEnergy (FE)
Legence Corp Cl A (LGN)
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Williams Companies (WMB)
MPLX Com Unit Rep Ltd (MPLX)
Targa Res Corp (TRGP)
Enterprise Products Partners (EPD)
Enbridge (ENB)
Kinder Morgan (KMI)
Energy Transfer Com Ut Ltd Ptn (ET)
Kinetik Holdings Com New Cl A (KNTK)
Cheniere Energy Com New (LNG)
PNM Resources (TXNM)

View all positions for Blackstone Group

Top funds holding Cytokinetics

T. Rowe Price Investment Management
BlackRock
FMR
Vanguard Group
Wellington Management Company
Vanguard Portfolio Management
State Street Corporation
Vanguard Capital Management
Geode Capital Management
Bank of America Corporation
Susquehanna International
Rtw Investments
Armistice Capital
Goldman Sachs Group
Polar Capital Holdings

View all funds holding Cytokinetics